It's critical that experiments in discovery are as clinically relevant as possible. Part of this effort is making cell-based in vitro models as relevant as possible, which can involve addressing very challenging variability and complexity. Join Kavita R. tomorrow as she takes us through her work at GSK where she was looking to develop multicellular cardiac models to test for cardiotoxicity. We're talking DOE, Synthace, SPT Labtech Dragonfly, and cells spontaneously starting to beat in multiwell plates. What's not to love? Maryia Karpiyevich, PhD and I will also be there. :) https://lnkd.in/dFK-SBYy #DOEforBiology #Automation #DrugDiscovery
Looking forward to learning more about this tomorrow
Looking forward to this!
Can't wait to watch tomorrow!
Will be great to learn more about the application of DoE to this biological application!
this post in 1 word Markus ? 😉
Can't wait!
Field Application Scientist at Synthace
4moSo cool. Love to see DOE + phenotyping!